Gentag, Mayo Clinic & Others Form Joint Venture To Develop Smartphone-Based Diabetes Technology

Building on the collaboration between Gentag and Mayo Clinic, and the collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide. Using their patented combined assets that include chemistry knowledge, proprietary sensor designs, and software and chip (ASIC) design capabilities, the four parties will combine to develop a mobile-phone based platform to bring low-cost, on-demand pain free diabetes monitoring to people worldwide.

The technology will use consumers . . .